TO MONITOR TREATMENT OF A LARGE COHORT OF PATIENTS WITH β-THALASSAEMIA MAJOR, INTERMEDIA & SICKLE CELL ANAEMIA IN ORDER TO ESTABLISH THE RESPONSE TO TRANS-RESVERATROL AND THE ASSOCIATED ELEMENTS. | Zendy

AI Assistant Blog Pricing

TO MONITOR TREATMENT OF A LARGE COHORT OF PATIENTS WITH β-THALASSAEMIA MAJOR, INTERMEDIA & SICKLE CELL ANAEMIA IN ORDER TO ESTABLISH THE RESPONSE TO TRANS-RESVERATROL AND THE ASSOCIATED ELEMENTS.

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.